Venoarterial extracorporeal membrane oxygenation (VA ECMO) is widely used in patients with cardiogenic shock. Insufficient decompression of the left ventricle (LV) is considered a major factor preventing adequate LV recovery. A 40-year-old male was diagnosed with acute myocardial infarction, and revascularization was performed using percutaneous stenting. However, cardiogenic shock occurred, and VA ECMO was initiated. Severe LV failure developed, and percutaneous transaortic catheter venting (TACV) was incorporated into the venous circuit of VA ECMO under transthoracic echocardiography guidance. The patient was successfully weaned from VA ECMO. Percutaneous TACV is an effective, relatively noninvasive, and rapid method of LV decompression in patients undergoing VA ECMO. 1A ). Although percutaneous stenting to the middle segment of the left anterior descending coronary artery was successful (Fig. 1B) , the patient's dyspnea was aggravated, with decreased O2 saturation (66%) that was not improved by immediate intubation and mechanical ventilation.
Venoarterial extracorporeal membrane oxygenation (VA ECMO) is widely used in patients with cardiogenic shock. Insufficient decompression of the left ventricle (LV) is considered a major factor preventing adequate LV recovery. A 40-year-old male was diagnosed with acute myocardial infarction, and revascularization was performed using percutaneous stenting. However, cardiogenic shock occurred, and VA ECMO was initiated. Severe LV failure developed, and percutaneous transaortic catheter venting (TACV) was incorporated into the venous circuit of VA ECMO under transthoracic echocardiography guidance. The patient was successfully weaned from VA ECMO. Percutaneous TACV is an effective, relatively noninvasive, and rapid method of LV decompression in patients undergoing VA ECMO. UT, USA) directly into the LV cavity across the aortic valve (Fig. 3) . Percutaneous transaortic catheter venting (TACV) was incorporated into the venous circuit of ECMO (Fig. 4A,   B ). The procedure was performed percutaneously, using a transfemoral approach. There were no complications related to the procedure. After the procedure, the patient's arterial blood pressure was elevated from 57/54 mmHg to 99/67 mmHg and above. An intra-aortic balloon pump (IABP) was inserted as a bridge therapy. In the Angioroom, ECMO was removed. On hospital day 6, the LVEF was measured as 58%, with IABP support. On hospital day 7, the patient's hemodynamic values had further stabilized and the IABP was removed. On the same day, it was possible to wean the patient from the ventilator and extubate him. The patient was weaned from all vasoactive/inotropic agents on hospital day 9. On hospital day 10, the patient was transferred to the general ward, because his general condition had undergone significant improvement.
On hospital day 15, he was discharged without complications.
DISCUSSION
VA ECMO is widely used in pediatric and adult patients with cardiogenic shock. However, some patients cannot be successfully weaned from VA ECMO support. Insufficient LV unloading is a main cause of unsuccessful LV recovery during VA ECMO [1] . Kurihara et al. [1] have suggested that TACV may be an adjunctive treatment to VA ECMO in patients with LV failure.
Dilatation of the LV may occur due to several factors: (1) the afterload induced by VA ECMO in cases of LV failure, (2) suboptimal venous return accompanying right heart recovery, (3) heavy collateral bronchial flow, and (4) aortic insufficiency [2] . The importance of left heart decompression during VA ECMO is generally recognized, but percutaneous drainage of the left heart is rarely reported and no consensus exists regarding the timing of LV decompression during VA ECMO.
In our hospital, we consider applying percutaneous TACV for LV decompression in patients who show either severe LV dysfunction (LVEF＜25%) with persistent pulmonary edema or asystole of the LV with or without mitral insufficiency.
Fumagalli et al. [3] were the first to report draining blood from the LV in a patient on VA ECMO as a bridge to heart transplantation, using a percutaneously placed transaortic cannula that pumped directly into the femoral artery, normalizing the left heart filling pressure and resolving pulmonary edema [3] . Kang et al. [4] reported a case of successful percutaneous trans-septal left atrial drainage using a 28-Fr cannula.
Nonetheless, left atrial drainage via septal puncture entails a risk of septal injury and/or a resultant left-to-right shunt.
Furthermore, it is debatable whether atrial decompression or ventricular decompression is more effective, especially in case Left-Heart Decompression during Extracorporeal Membrane Oxygenation − 213 − of severe distension with asystole of the LV. We are of the opinion that left atrial drainage can avoid pulmonary edema, but has no effect on LV decompression in the absence of mitral insufficiency in cases of LV asystole. The other method of LV decompression is the use of the Impella LP 2.5 device, as reported by Koeckert et al. [5] . The use of the Impella LP 2.5 device for LV decompression is an expensive technique. Although an IABP can decrease LV afterload, doing so has no direct effect on LV decompression. Despite the use of a relatively small catheter (5 Fr), immediate decompression was possible in our case within a few hours, suggesting that direct ventricular decompression may be a more effective and faster method.
In summary, our patient was successfully treated with percutaneous TACV, which is an effective, relatively noninvasive, and rapid method of left heart decompression in patients undergoing VA ECMO.
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